您当前所在的位置:首页 > 产品中心 > 产品详细信息
40431-64-9 分子结构
点击图片或这里关闭

methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate

ChemBase编号:4439
分子式:C14H19NO2
平均质量:233.30616
单一同位素质量:233.14157885
SMILES和InChIs

SMILES:
O(C(=O)[C@@H]([C@@H]1NCCCC1)c1ccccc1)C
Canonical SMILES:
COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1
InChI:
InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1
InChIKey:
DUGOZIWVEXMGBE-CHWSQXEVSA-N

引用这个纪录

CBID:4439 http://www.chembase.cn/molecule-4439.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate
IUPAC传统名
focalin
商标名
Focalin
别名
Dexmethylphenidate
CAS号
40431-64-9
PubChem SID
160967871
99443255
PubChem CID
4158
154101

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID
DrugBank DB06701 external link
PubChem 154101 external link
数据来源 数据ID 价格

理论计算性质

理论计算性质

JChem ALOGPS 2.1
质子受体 质子供体
LogD (pH = 5.5) -0.8258359  LogD (pH = 7.4) 0.5692904 
Log P 2.254935  摩尔折射率 66.7282 cm3
极化性 26.621723 Å3 极化表面积 38.33 Å2
可自由旋转的化学键 里宾斯基五规则 true 
Log P 1.47  LOG S -3.11 
溶解度 1.82e-01 g/l 

分子性质

分子性质

生物活性(PubChem)

详细说明

详细说明

DrugBank DrugBank
DrugBank -  DB06701 external link
Item Information
Drug Groups approved
Description Dexmethylphenidate is the dextrorotary form of methylphenidate. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and thus a psychostimulant. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Indication Dexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment.
Pharmacology Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy.
Toxicity Insomnia, dizziness, nausea, stomach pain, euphoria, headache, anxiety, anorexia, and weight loss are common side effects.
Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)
Affected Organisms
Humans and other mammals
Biotransformation epatic, methylphenidate is metabolized primarily by de-esterification to ritalinic acid (α-phenyl-2-piperidine acetic acid, PPAA), which has little to no pharmacologic activity.
Absorption 11-52%
Half Life 2-4 hours
Protein Binding 30%
Elimination Renal
External Links
Wikipedia

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    暂无数据
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle